412210000: Insulin lispro (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\...

\Pancreatic hormone\Insulin\Human insulin\Insulin lispro

\Polypeptide hormone\Insulin\Human insulin\Insulin lispro

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\...

\Pancreatic hormone\Insulin\Human insulin\Insulin lispro

\Polypeptide hormone\Insulin\Human insulin\Insulin lispro

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\...

\Polypeptide\Polypeptide hormone\Insulin\Human insulin\Insulin lispro

\Pancreatic hormone\Insulin\Human insulin\Insulin lispro

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\...

\Polypeptide\Polypeptide hormone\Insulin\Human insulin\Insulin lispro

\Pancreatic hormone\Insulin\Human insulin\Insulin lispro

\Biological substance\Polypeptide\Polypeptide hormone\Insulin\Human insulin\Insulin lispro

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2004. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Insulin lispro	Is a	Human insulin	true	Inferred relationship	Some
Insulin lispro	Is a	Short-acting insulin	false	Inferred relationship	Some
Insulin lispro	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Pancreatic hormone (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing insulin lispro and insulin lispro protamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Insulin lispro	Inferred relationship	Some
Insulin biphasic lispro 25/75 100u/mL injection solution 3mL prefilled pen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Insulin lispro	Inferred relationship	Some
Insulin biphasic lispro 50/50 100u/mL injection solution 3mL prefilled pen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Insulin lispro	Inferred relationship	Some
Insulin biphasic lispro 25/75 100u/mL injection solution 3mL cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Insulin lispro	Inferred relationship	Some
Product containing insulin lispro (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Insulin lispro	Inferred relationship	Some	1
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 3ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Insulin lispro	Inferred relationship	Some
Insulin lispro biphasic (recombinant human insulin analogue) 50/50 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Insulin lispro	Inferred relationship	Some
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 10ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Insulin lispro	Inferred relationship	Some
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Insulin lispro	Inferred relationship	Some
Insulin lispro biphasic (recombinant human insulin analogue) human 25/75 100units/ml injection 3ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Insulin lispro	Inferred relationship	Some
Insulin lispro biphasic (recombinant human insulin analogue) 25/75 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Insulin lispro	Inferred relationship	Some
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Insulin lispro	Inferred relationship	Some
insuline lispro 100 unités/mL, flacon de 10 mL de solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Insulin lispro	Inferred relationship	Some
insuline lispro 100 unités/mL, cartouche de 3 mL de solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Insulin lispro	Inferred relationship	Some
insuline lispro 100 unités/mL, stylo prérempli de 3 mL de solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Insulin lispro	Inferred relationship	Some
Insulin lispro 100u/mL injection solution 1.5mL cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Insulin lispro	Inferred relationship	Some
Product containing insulin lispro biphasic	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Insulin lispro	Inferred relationship	Some
Insulin lispro protamine (substance)	Is a	False	Insulin lispro	Inferred relationship	Some
Insulin lispro-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Insulin lispro	Inferred relationship	Some	1
Product containing precisely lispro insulin 150 unit/1.5 milliliter conventional release solution for injection cartridge	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Insulin lispro	Inferred relationship	Some	1
Product containing precisely lispro insulin 150 unit/1.5 milliliter conventional release solution for injection cartridge	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Insulin lispro	Inferred relationship	Some	1
Product containing precisely lispro insulin 1000 unit/10 milliliter conventional release solution for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Insulin lispro	Inferred relationship	Some	1
Product containing precisely lispro insulin 1000 unit/10 milliliter conventional release solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Insulin lispro	Inferred relationship	Some	1
Product containing precisely lispro insulin 300 unit/3 milliliter conventional release solution for injection cartridge	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Insulin lispro	Inferred relationship	Some	1
Product containing precisely lispro insulin 300 unit/3 milliliter conventional release solution for injection cartridge	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Insulin lispro	Inferred relationship	Some	1
Product containing precisely lispro insulin 300 unit/3 milliliter conventional release solution for injection syringe	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Insulin lispro	Inferred relationship	Some	1
Product containing precisely lispro insulin 300 unit/3 milliliter conventional release solution for injection syringe	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Insulin lispro	Inferred relationship	Some	1
Insulin lispro only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Insulin lispro	Inferred relationship	Some	1
Product containing only insulin lispro in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Insulin lispro	Inferred relationship	Some	1
Product containing precisely insulin lispro 100 unit/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Insulin lispro	Inferred relationship	Some	1
Product containing precisely insulin lispro 100 unit/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Insulin lispro	Inferred relationship	Some	1
Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Insulin lispro	Inferred relationship	Some	1
Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Insulin lispro	Inferred relationship	Some	1
Product containing precisely insulin lispro 50 unit/1 milliliter and insulin lispro protamine 50 unit/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Insulin lispro	Inferred relationship	Some	1
Product containing precisely insulin lispro 50 unit/1 milliliter and insulin lispro protamine 50 unit/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Insulin lispro	Inferred relationship	Some	1
Insulin lispro protamine (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	False	Insulin lispro	Inferred relationship	Some
Product containing insulin lispro and insulin lispro protamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Insulin lispro	Inferred relationship	Some	2
Product containing only insulin lispro and insulin lispro protamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Insulin lispro	Inferred relationship	Some	1
Product containing insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Insulin lispro	Inferred relationship	Some	1
Product containing only insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Insulin lispro	Inferred relationship	Some	1
Product containing precisely insulin lispro 200 unit/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Insulin lispro	Inferred relationship	Some	1
Product containing precisely insulin lispro 200 unit/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Insulin lispro	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2473802011	Lispro insulin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2693906011	Insulin lispro	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3719240018	Insulin lispro (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
56421000195114	insulina lispro	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
6291000188114	insuline lispro	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
71421000195115	Insulin lispro	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module